Teriparatide therapy enhances devitalized femoral allograft osseointegration and biomechanics in a murine model

Bone

Volumn 48, Issue 3, 2011, Pages 562-570

  Reynolds, David G ^a,b   Takahata, Masahiko ^b   Lerner, Amy L ^a,b   O'Keefe, Regis J ^b   Schwarz, Edward M ^a,b   Awad, Hani A ^a,b  

^a University of Rochester   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Allograft; Biomechanics; Bone; Micro computed tomography; PTH

Indexed keywords

PARATHYROID HORMONE[1-34]; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE ALLOGRAFT; BONE DEFECT; BONE DENSITY; BONE REGENERATION; BONE STRENGTH; CALLUS; CONTROLLED STUDY; CORTICAL BONE; DRUG EFFICACY; FEMALE; FEMORAL ALLOGRAFT; FEMORAL DEFECT; FRACTURE HEALING; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSSIFICATION; TRABECULAR BONE; TREATMENT DURATION; TREATMENT RESPONSE;

ANIMALS; BIOMECHANICS; FEMUR; LINEAR MODELS; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; OSSEOINTEGRATION; OSTEOGENESIS; TERIPARATIDE; TORSION, MECHANICAL; TRANSPLANTATION, HOMOLOGOUS; WOUND HEALING; X-RAY MICROTOMOGRAPHY;

EID: 79751524079     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.10.003     Document Type: Article

References (42)

1. Busse J.W., Jacobs C.L., Swiontkowski M.F., Bosse M.J., Bhandari M. Complex limb salvage or early amputation for severe lower-limb injury: a meta-analysis of observational studies. J Orthop Trauma 2007, 21:70-76.
2. Bosse M.J., MacKenzie E.J., Kellam J.F., Burgess A.R., Webb L.X., Swiontkowski M.F., et al. An analysis of outcomes of reconstruction or amputation after leg-threatening injuries. N Engl J Med 2002, 347:1924-1931.
3. MacKenzie E.J., Jones A.S., Bosse M.J., Castillo R.C., Pollak A.N., Webb L.X., et al. Health-care costs associated with amputation or reconstruction of a limb-threatening injury. J Bone Joint Surg Am 2007, 89:1685-1692.
4. Covey D.C., Aaron R.K., Born C.T., Calhoun J.H., Einhorn T.A., Hayda R.A., et al. Orthopaedic war injuries: from combat casualty care to definitive treatment: a current review of clinical advances, basic science, and research opportunities. Instr Course Lect 2008, 57:65-86.
5. Wheeler D.L., Enneking W.F. Allograft bone decreases in strength in vivo over time. Clin Orthop Relat Res 2005, 36-42.
6. Mankin H.J. The current state of limb salvage surgery. Skeletal Radiol 2009, 38:733-734.
7. Jahng J.S., Kim H.W. Effect of intermittent administration of parathyroid hormone on fracture healing in ovariectomized rats. Orthopedics 2000, 23:1089-1094.
8. Chen H., Frankenburg E.P., Goldstein S.A., McCauley L.K. Combination of local and systemic parathyroid hormone enhances bone regeneration. Clin Orthop Relat Res 2003, 291-302.
9. Alkhiary Y.M., Gerstenfeld L.C., Krall E., Westmore M., Sato M., Mitlak B.H., et al. Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). J Bone Joint Surg Am 2005, 87:731-741.
10. Nakazawa T., Nakajima A., Shiomi K., Moriya H., Einhorn T.A., Yamazaki M. Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing. Bone 2005, 37:711-719.
11. Barnes G.L., Kakar S., Vora S., Morgan E.F., Gerstenfeld L.C., Einhorn T.A. Stimulation of fracture-healing with systemic intermittent parathyroid hormone treatment. J Bone Joint Surg Am 2008, 90(Suppl 1):120-127.
12. Komatsu D.E., Brune K.A., Liu H., Schmidt A.L., Han B., Zeng Q.Q., et al. Longitudinal in vivo analysis of the region-specific efficacy of parathyroid hormone in a rat cortical defect model. Endocrinology 2009, 150:1570-1579.
13. Puzas J.E., Houck J., Bukata S.V. Accelerated fracture healing. J Am Acad Orthop Surg 2006, 14:S145-S151.
14. Tiyapatanaputi P., Rubery P.T., Carmouche J., Schwarz E.M., O'Keefe R.J., Zhang X. A novel murine segmental femoral graft model. J Orthop Res 2004, 22:1254-1260.
15. Ito H., Koefoed M., Tiyapatanaputi P., Gromov K., Goater J.J., Carmouche J., et al. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy. Nat Med 2005, 11:291-297.
16. Koefoed M., Ito H., Gromov K., Reynolds D.G., Awad H.A., Rubery P.T., Ulrich-Vinther M., Soballe K., Guldberg R.E., Lin A.S., O'Keefe R.J., Zhang X., Schwarz E.M. Biological effects of rAAV-caAlk2 coating on structural allograft healing. Mol Ther 2005, 12:212-218.
17. Reynolds D.G., Shaikh S., Papuga M.O., Lerner A.L., O'Keefe R.J., Schwarz E.M., et al. muCT-based measurement of cortical bone graft-to-host union. J Bone Miner Res 2009, 24:899-907.
18. Reynolds D.G., Hock C., Shaikh S., Jacobson J., Zhang X., Rubery P.T., et al. Micro-computed tomography prediction of biomechanical strength in murine structural bone grafts. J Biomech 2007, 40:3178-3186.
19. Awad H.A., Zhang X., Reynolds D.G., Guldberg R.E., O'Keefe R.J., Schwarz E.M. Recent advances in gene delivery for structural bone allografts. Tissue Eng 2007, 13:1973-1985.
20. Brigman B.E., Hornicek F.J., Gebhardt M.C., Mankin H.J. Allografts about the knee in young patients with high-grade sarcoma. Clin Orthop Relat Res 2004, 232-239.
21. Berrey B.H., Lord C.F., Gebhardt M.C., Mankin H.J. Fractures of allografts. Frequency, treatment, and end-results. J Bone Joint Surg Am 1990, 72:825-833.
22. Xie C., Reynolds D., Awad H., Rubery P.T., Pelled G., Gazit D., et al. Structural bone allograft combined with genetically engineered mesenchymal stem cells as a novel platform for bone tissue engineering. Tissue Eng 2007, 13:435-445.
23. Lucarelli E., Fini M., Beccheroni A., Giavaresi G., Di Bella C., Aldini N.N., et al. Stromal stem cells and platelet-rich plasma improve bone allograft integration. Clin Orthop Relat Res 2005, 62-68.
24. Yan M.N., Dai K.R., Tang T.T., Zhu Z.A., Lou J.R. Reconstruction of peri-implant bone defects using impacted bone allograft and BMP-2 gene-modified bone marrow stromal cells. J Biomed Mater Res A 2009, 93A:304-313.
25. Jones A.L., Bucholz R.W., Bosse M.J., Mirza S.K., Lyon T.R., Webb L.X., et al. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects. A randomized, controlled trial. J Bone Joint Surg Am 2006, 88:1431-1441.
26. Reeve J., Meunier P.J., Parsons J.A., Bernat M., Bijvoet O.L., Courpron P., et al. Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. Br Med J 1980, 280:1340-1344.
27. Reeve J., Arlot M., Bernat M., Charhon S., Edouard C., Slovik D., et al. Calcium-47 kinetic measurements of bone turnover compared to bone histomorphometry in osteoporosis: the influence of human parathyroid fragment (hPTH 1-34) therapy. Metab Bone Dis Relat Res 1981, 3:23-30.
28. Slovik D.M., Neer R.M., Potts J.T. Short-term effects of synthetic human parathyroid hormone-(1-34) administration on bone mineral metabolism in osteoporotic patients. J Clin Invest 1981, 68:1261-1271.
29. Nakajima A., Shimoji N., Shiomi K., Shimizu S., Moriya H., Einhorn T.A., et al. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). J Bone Miner Res 2002, 17:2038-2047.
30. Andreassen T.T., Willick G.E., Morley P., Whitfield J.F. Treatment with parathyroid hormone hPTH(1-34), hPTH(1-31), and monocyclic hPTH(1-31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase. Calcif Tissue Int 2004, 74:351-356.
31. Komatsubara S., Mori S., Mashiba T., Nonaka K., Seki A., Akiyama T., et al. Human parathyroid hormone (1-34) accelerates the fracture healing process of woven to lamellar bone replacement and new cortical shell formation in rat femora. Bone 2005, 36:678-687.
32. Manabe T., Mori S., Mashiba T., Kaji Y., Iwata K., Komatsubara S., et al. Human parathyroid hormone (1-34) accelerates natural fracture healing process in the femoral osteotomy model of cynomolgus monkeys. Bone 2007, 40:1475-1482.
33. Pettway G.J., Schneider A., Koh A.J., Widjaja E., Morris M.D., Meganck J.A., et al. Anabolic actions of PTH (1-34): use of a novel tissue engineering model to investigate temporal effects on bone. Bone 2005, 36:959-970.
34. Bonadio J., Smiley E., Patil P., Goldstein S. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med 1999, 5:753-759.
35. Aspenberg P., Genant H.K., Johansson T., Nino A.J., See K., Krohn K., et al. Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures. J Bone Miner Res 2010, 25:404-414.
36. Hashimoto T., Shigetomi M., Ohno T., Matsunaga T., Muramatsu K., Tanaka H., et al. Sequential treatment with intermittent low-dose human parathyroid hormone (1-34) and bisphosphonate enhances large-size skeletal reconstruction by vascularized bone transplantation. Calcif Tissue Int 2007, 81:232-239.
37. Abe Y., Takahata M., Ito M., Irie K., Abumi K., Minami A. Enhancement of graft bone healing by intermittent administration of human parathyroid hormone (1-34) in a rat spinal arthrodesis model. Bone 2007, 41:775-785.
38. Schmidt I.U., Dobnig H., Turner R.T. Intermittent parathyroid hormone treatment increases osteoblast number, steady state messenger ribonucleic acid levels for osteocalcin, and bone formation in tibial metaphysis of hypophysectomized female rats. Endocrinology 1995, 136:5127-5134.
39. Jilka R.L., Weinstein R.S., Bellido T., Roberson P., Parfitt A.M., Manolagas S.C. Increased bone formation by prevention of osteoblast apoptosis with parathyroid hormone. J Clin Invest 1999, 104:439-446.
40. Pettway G.J., Meganck J.A., Koh A.J., Keller E.T., Goldstein S.A., McCauley L.K. Parathyroid hormone mediates bone growth through the regulation of osteoblast proliferation and differentiation. Bone 2008, 42:806-818.
41. Dobnig H., Turner R.T. Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 1995, 136:3632-3638.
42. Kakar S., Einhorn T.A., Vora S., Miara L.J., Hon G., Wigner N.A., et al. Enhanced chondrogenesis and Wnt signaling in PTH-treated fractures. J Bone Miner Res 2007, 22:1903-1912.